Lukacs N W, Kunkel S L, Strieter R M, Warmington K, Chensue S W
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109.
J Exp Med. 1993 Jun 1;177(6):1551-9. doi: 10.1084/jem.177.6.1551.
Macrophage inflammatory protein 1 alpha (MIP-1 alpha) is a 6-8-kD, lipopolysaccharide-inducible monocyte and neutrophil chemotactic protein that may be important in acute and chronic inflammation. The present study determined the sequential production, source, and in vivo contribution of murine MIP-1 alpha in synchronized Schistosoma mansoni egg pulmonary granuloma formation. Granulomas were examined under conditions of primary, secondary vigorous, and secondary immunomodulated immunity. Secreted MIP-1 alpha was measured in 24-h supernatants from intact granulomas (700/ml) cultured with or without soluble egg antigen (SEA). Primary granulomas isolated from naive mice over a 16-d period showed low spontaneous MIP-1 alpha production (< 1 ng/ml). However, when primary granulomas were challenged with SEA, significant MIP-1 alpha production was observed beginning at day 4 and peaking at day 16. Intact vigorous (isolated from 8-wk-infected mice) and modulated (isolated from 20-wk-infected mice) secondary pulmonary granulomas demonstrated comparable spontaneous MIP-1 alpha production. Addition of SEA to vigorous stage granulomas augmented expression of MIP-1 alpha at all time points, whereas stimulated modulated stage granulomas did not increase production. The latter observation is likely related to endogenous immunoregulatory mechanisms reported for modulated stage animals. Immunohistochemical localization of MIP-1 alpha in granuloma sections and cytocentrifuge preparations from vigorous lesions localized MIP-1 alpha production to macrophages within granulomas. Treatment of mice with rabbit anti-mouse MIP-1 alpha antibodies significantly decreased 8-d primary granuloma formation (> 40%) when compared with control mice. Anti-MIP-1 alpha sera also decreased vigorous (> 20%), but not modulated granuloma formation. These findings demonstrate that MIP-1 alpha contributes to cellular recruitment during schistosome egg granuloma formation.
巨噬细胞炎性蛋白1α(MIP-1α)是一种6-8kD的脂多糖诱导型单核细胞和中性粒细胞趋化蛋白,在急性和慢性炎症中可能起重要作用。本研究确定了小鼠MIP-1α在曼氏血吸虫卵肺肉芽肿同步形成过程中的顺序产生、来源及体内作用。在初次、二次强烈免疫和二次免疫调节免疫条件下检查肉芽肿。在用或不用可溶性虫卵抗原(SEA)培养的完整肉芽肿(700/ml)的24小时上清液中测量分泌的MIP-1α。在16天期间从未感染小鼠分离的初次肉芽肿显示出低水平的自发MIP-1α产生(<1ng/ml)。然而,当用SEA刺激初次肉芽肿时,从第4天开始观察到显著的MIP-1α产生,并在第16天达到峰值。完整的强烈免疫(从感染8周的小鼠分离)和调节免疫(从感染20周的小鼠分离)的二次肺肉芽肿显示出相当的自发MIP-1α产生。向强烈免疫阶段的肉芽肿中添加SEA在所有时间点均增强了MIP-1α的表达,而刺激调节免疫阶段的肉芽肿并未增加其产生。后一观察结果可能与调节免疫阶段动物报道的内源性免疫调节机制有关。MIP-1α在肉芽肿切片和来自强烈病变的细胞离心制备物中的免疫组织化学定位将MIP-1α的产生定位到肉芽肿内的巨噬细胞。与对照小鼠相比,用兔抗小鼠MIP-1α抗体治疗小鼠可显著减少8天初次肉芽肿的形成(>40%)。抗MIP-1α血清也减少了强烈免疫肉芽肿的形成(>20%),但未减少调节免疫肉芽肿的形成。这些发现表明MIP-1α在血吸虫卵肉芽肿形成过程中有助于细胞募集。